Genetic Basis of Hypersusceptibility to Protease Inhibitors and Low Replicative Capacity of Human Immunodeficiency Virus Type 1 Strains in Primary Infection

The initial virus strains from as many as 12% of individuals with primary human immunodeficiency virus (HIV) infection have a 50% inhibitory concentration ≤0.4-fold that of HIV type 1(NL4-3) (HIV-1(NL4-3)) to ritonavir (hypersusceptibility [HS]). There is also substantial variation in replicative ca...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Leigh Brown, Andrew J., Frost, Simon D. W., Good, Benjamin, Daar, Eric S., Simon, Viviana, Markowitz, Martin, Collier, Ann C., Connick, Elizabeth, Conway, Brian, Margolick, Joseph B., Routy, Jean-Pierre, Corbeil, Jacques, Hellmann, Nicholas S., Richman, Douglas D., Little, Susan J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2004
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC369210/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14963120/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.5.2242-2246.2004
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!